156 Episodo

  1. Tuberculosis and the microbiome

    Publicado: 3/9/2019

  2. Antibiotics and non-severe exacerbations of bronchiectasis in children

    Publicado: 16/8/2019

  3. Use of extended-criteria donors for lung transplantation

    Publicado: 6/8/2019

  4. α1-antitrypsin deficiency testing

    Publicado: 30/7/2019

  5. Live-attenuated influenza vaccines in children

    Publicado: 24/6/2019

  6. Clearing the air on ambient air pollution

    Publicado: 19/6/2019

  7. A second look at FEAST

    Publicado: 12/6/2019

  8. Intensive care units and the USA

    Publicado: 21/5/2019

  9. A respiratory family affair

    Publicado: 17/4/2019

  10. A global approach to children's asthma

    Publicado: 22/2/2019

  11. The effectiveness of pleural manometry

    Publicado: 14/2/2019

  12. Lung volume reduction and emphysema

    Publicado: 8/2/2019

  13. Glimmers of hope for MDR-Tuberculosis treatment

    Publicado: 8/1/2019

  14. Effectiveness of flu vaccine over time

    Publicado: 16/11/2018

  15. Towards an International Pneumonia Network

    Publicado: 12/11/2018

  16. Laparoscopic anti-reflux surgery and IPF

    Publicado: 2/11/2018

  17. Improving the lives of patients with bronchiectasis

    Publicado: 20/9/2018

  18. Deep learning and fibrotic lung disease

    Publicado: 17/9/2018

  19. Critical care and infant nutrition

    Publicado: 15/9/2018

  20. Precision medicine in ARDS

    Publicado: 3/8/2018

4 / 8

Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.

Visit the podcast's native language site